Xiamen Huanyu Pharmaceutical
Xiamen Huanyu Pharmaceutical's strongest tracked position is the Chitosan Market at an estimated 1.5% share in a market growing at 12.9% CAGR.
Meridian Consensus tracks Xiamen Huanyu Pharmaceutical in 1 market across 1 industry (Chemical). Estimated in-market revenue is $89M, the sum of share × market size across appearances — a modeled figure, not reported company revenue.
Share and revenue figures are Meridian model estimates reconciled through the publish-gate validator, not audited financials. Methodology
Market positions
| Market | CAGR | Share |
|---|---|---|
| Chitosan Market | 12.9% | 1.5% |
Meridian Dossier
Need diligence-grade depth on Xiamen Huanyu Pharmaceutical?
Commission a source-cited diligence dossier on Xiamen Huanyu Pharmaceutical: identity, filed financials, IP, litigation, and government exposure. Free preview first, from $299.
Xiamen Huanyu Pharmaceutical: frequently asked
Meridian Consensus tracks Xiamen Huanyu Pharmaceutical in 1 market: Chitosan Market ($5.9B), spanning Chemical.
Xiamen Huanyu Pharmaceutical's strongest tracked position is the Chitosan Market, a $5.9B market growing at 12.9% CAGR, where it holds an estimated 1.5% share as of June 2026.
Across Meridian-tracked markets, Xiamen Huanyu Pharmaceutical's closest peers are Primex, KitoZyme, Heppe Medical Chitosan, G.T.C. Bio Corporation, Kunpoong Bio, with the largest overlap in the Chitosan Market. Peer mapping is based on co-appearance in the same tracked markets.
No. Share and revenue figures on this page are model estimates produced by Meridian's research pipeline and committee-reviewed before publication; they are not audited or exchange-filed financials. Market-level sizings are reconciled against external sources during the publish gate.
Adjacent markets in Chemical
Tracked markets in the same industry where Xiamen Huanyu Pharmaceutical is not among the named operators. Each carries Porter Five Forces, SWOT, country analysis, and a full competitor table.
Operators that compete with Xiamen Huanyu Pharmaceutical
Xiamen Huanyu Pharmaceutical's closest peers across Meridian-tracked markets are Primex, KitoZyme, Heppe Medical Chitosan, among others, ordered by how many tracked markets they share with the operator.
- 1 sharedPrimexTop overlap · Chitosan
- 1 sharedKitoZymeTop overlap · Chitosan
- 1 sharedHeppe Medical ChitosanTop overlap · Chitosan
- 1 sharedG.T.C. Bio CorporationTop overlap · Chitosan
- 1 sharedKunpoong BioTop overlap · Chitosan
- 1 sharedZhejiang Golden-Shell PharmaceuticalTop overlap · Chitosan
- 1 sharedQingdao Yunzhou BiochemistryTop overlap · Chitosan
- 1 sharedWeikang GroupTop overlap · Chitosan
- 1 sharedFMC CorporationTop overlap · Chitosan
- 1 sharedDainichiseika Color & ChemicalsTop overlap · Chitosan
Or browse the full A–Z operator directory for any company in the catalogue.
Meridian Consensus Digest
Free · WeeklyNot ready to commission a full report? Get our weekly briefing instead: new market sizings, thesis revisions, and reconciliation updates. Signed by the research team. No sales emails.